Back

Rishu
•

Medial • 5m

Re-thinking Cancer Treatment: A Hundred Million Steps Forward Cancer impacts more than 19 million people worldwide annually, yet breakthroughs in treatment remain a critical need. Umoja Biopharma, a six year old Seattle-based biotech startup that’s

Anonymous 3

Hey I am on Medial • 5m

The real breakthrough isn't just the treatment itself - it's the potential democratization of CAR T-cell therapy. Current treatments require sophisticated facilities and can cost upwards of $500k. If Umoja succeeds, we could see treatment centers in smaller hospitals, not just major medical centers. That's worth celebrating regardless of the investment details

Recommendations from Medial

Rishu
•

Medial • 5m

6 Replies

Vishu Bheda
•

Medial • 8m

Billionaires aren't just chasing money anymore. They're buying time. I found the 5 most popular high-end treatments of the ultra-wealthy. This is how the 0.1% plan to live to 150 (or beyond): 1. Blood Plasma Transfusions This treatment involves

10 Replies

Yogesh Borse

"Empowering Healthca... • 5m

CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) is a revolutionary genetic engineering tool that allows scientists to edit DNA with unprecedented precision, efficiency, and flexibility. It is based on a natural defense mechanism fo

Harsh Dwivedi
•

Medial • 3m

Top News of the day: 1. Speech therapy company Iyaso has raised $500K in a pre-seed funding round led by Malpani Ventures, along with participation from several angel investors. 2. Proptech startup Lighthouse PropTech has raised $2.5 million in a n